Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15169)	2/17/1998 11:19:00 AM
From: Allan Harris	Read Replies (1) \| Respond to of 32384

Can someone post a quick heads-up on the warrants, LGNDW? 1. Conversion price? 2. Callable? 3. Expiration? 4. Why the huge spread (8 1/8 - 8 5/8)? Thanks, Allan

To: Henry Niman who wrote (15169)	2/17/1998 11:30:00 AM
From: Andreas Helke	Read Replies (1) \| Respond to of 32384

Here is what Zacks has to say about its service at the INVESTtools web site: About Zacks Investment Research The most powerful force driving stock prices is changes in earnings per share (EPS) estimates by analysts at major brokerage firms. Here's why: as analysts revise their earnings estimates and change their recommendations, this represents new information that has not yet been discounted in stock prices. Investors with access to this new information, while it is still new, enjoy a tremendous advantage in identifying which stocks will most radically outperform the market, and which will most underperform it. Every week Zacks Investment Research records over 15,000 such changes, made by over 3500 analysts at over 210 brokerage firms covering 5,000 companies. From this data, Zacks derives consensus earnings estimates and tracks every single revision in these estimates.